Literature DB >> 28867748

Higher incidence of nasopharyngeal carcinoma in some regions in the world confers for interplay between genetic factors and external stimuli.

Nabanita Roy Chattopadhyay1, Piyanki Das1, Koustav Chatterjee, Tathagata Choudhuri1.   

Abstract

Nasopharyngeal carcinoma (NPC) is a rare variety of head and neck cancers. The risk factors include three major causes: genetic factors, viral infection, and environmental and dietary factors. The types of NPC show strong ethnic and geographic variations. The keratinizing and non-keratinizing types are prevalent in the lower incidence regions like North America and Europe; whereas the undifferentiated type is mostly found in the regions with higher incidences like China, North Africa, Arctic, and Nagaland of North-East India. These suggest a possible major role of the internal genetic factors for generation and promotion of this disease. Viral infections might accelerate the process of carcinogenesis by helping in cellular proliferation and loss of apoptosis. Diet and other environmental factors promote these neoplastic processes and further progression of the disease occurs.

Entities:  

Keywords:  Nasopharyngeal carcinoma; North-East India; ethnic variation; incidence; undifferentiated NPC

Mesh:

Year:  2017        PMID: 28867748     DOI: 10.5582/ddt.2017.01030

Source DB:  PubMed          Journal:  Drug Discov Ther        ISSN: 1881-7831


  8 in total

1.  LncRNA ZNF667-AS1 Promotes ABLIM1 Expression by Adsorbing micro RNA-1290 to Suppress Nasopharyngeal Carcinoma Cell Progression.

Authors:  Xi Chen; Yaping Huang; Dianyu Shi; Chuan Nie; Yiping Luo; Liangfen Guo; Yu Zou; Chun Xie
Journal:  Onco Targets Ther       Date:  2020-05-20       Impact factor: 4.147

2.  Reappraisal of the incidence, various types and risk factors of malignancies in patients with dermatomyositis and polymyositis in Taiwan.

Authors:  Jung-Lung Hsu; Ming-Feng Liao; Chun-Che Chu; Hung-Chou Kuo; Rong-Kuo Lyu; Hong-Shiu Chang; Chiung-Mei Chen; Yih-Ru Wu; Kuo-Hsuan Chang; Yi-Ching Weng; Chun-Wei Chang; Hsing-I Chiang; Chih-Kuang Cheng; Pai-Wei Lee; Chin-Chang Huang; Long-Sun Ro
Journal:  Sci Rep       Date:  2021-02-25       Impact factor: 4.379

3.  Research status and prospects of biomarkers for nasopharyngeal carcinoma in the era of high‑throughput omics (Review).

Authors:  Shan-Qiang Zhang; Su-Ming Pan; Si-Xian Liang; Yu-Shuai Han; Hai-Bin Chen; Ji-Cheng Li
Journal:  Int J Oncol       Date:  2021-03-02       Impact factor: 5.650

4.  Screening and bioinformatical analysis of differentially expressed genes in nasopharyngeal carcinoma.

Authors:  Weiqian Guo; Xiaomin Zheng; Lei Hua; Xianbin Zheng; Yangyang Zhang; Bin Sun; Zhenchao Tao; Jin Gao
Journal:  J Cancer       Date:  2021-01-30       Impact factor: 4.207

5.  MicroRNA-613 Enhances Nasopharyngeal Carcinoma Cell Radiosensitivity via the DNA Methyltransferase 3B/Tissue Inhibitor of Matrix Metalloproteinase-3/Signal Transducer and Activator of Transcription-1/Forkhead Box O-1 Axis.

Authors:  Liqiang Deng; Qing Yin; Shuyun Liu; Debao Luo
Journal:  Dis Markers       Date:  2022-08-26       Impact factor: 3.464

6.  The effect of histological subtypes on survival outcome in nasopharyngeal carcinoma after extensive follow up.

Authors:  San-Gang Wu; Chen-Lu Lian; Jun Wang; Wen-Wen Zhang; Jia-Yuan Sun; Qin Lin; Zhen-Yu He
Journal:  Ann Transl Med       Date:  2019-12

7.  Epstein-Barr virus nuclear antigen-1 is useful as therapeutic efficacy marker in serum but not in saliva of nasopharyngeal cancer patients who underwent radiotherapy.

Authors:  Yurnadi H Midoen; Dwi A Suryandari; Luluk Yunaini; Raden Susworo; Elza I Auerkari; Hans-Joachim Freisleben
Journal:  Ecancermedicalscience       Date:  2021-06-21

8.  Nasopharyngeal Carcinoma (NPC) Risk Factors: A Systematic Review and Meta-Analysis of the Association with Lifestyle, Diets, Socioeconomic and Sociodemographic in Asian Region.

Authors:  Simon I Okekpa; Rabiatul Basria S M N Mydin; Ernest Mangantig; Nor Syaffaf Amaliana Azmi; Siti Nur Syahirah Zahari; Gurjeet Kaur; Yusri Musa
Journal:  Asian Pac J Cancer Prev       Date:  2019-11-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.